Is Arrowhead Pharmaceuticals (ARWR) Stock Price Out Of Line With Recent 1-Year Surge?
- If you are wondering whether Arrowhead Pharmaceuticals’ current share price lines up with its fundamentals, this article walks through the key valuation angles that matter to you.
- The stock last closed at US$74.81, with returns of 1.2% over 7 days, 18.9% over 30 days, 10.4% year to date, 418.8% over 1 year and 80.8% over 3 years, compared with 12.7% over 5 years.
- Recent market focus around Arrowhead Pharmaceuticals has centred on its position in the biopharmaceutical space and ongoing interest in RNA based therapies. This context helps frame why shorter term moves sit alongside a very strong 1 year return figure.
- Arrowhead Pharmaceuticals currently has a valuation score of 2 out of 6. The next sections break down what different…
Source link
